Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Keybanc Maintains Overweight on Phreesia, Raises Price Target to $45

By Benzinga Newsdesk
Today, 7:30 AM
Keybanc analyst Scott Schoenhaus maintains Phreesia (NYSE:PHR) with a Overweight and raises the price target from $40 to $45.

PHR

Read More
1 minute read
  • Analyst Ratings

Analyst Expectations for Phreesia’s Future

By Benzinga Insights
Today, 7:30 AM
Phreesia (NYSE:PHR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PHR

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

Needham Remains Bullish On Phreesia & Udemy; Adds Both To Conviction List

By Anusuya Lahiri
Today, 7:30 AM
Needham analyst Ryan MacDonald maintained Phreesia Inc (NYSE:PHR) with a Buy and raised the price target from $35 to $40. The analyst…

PHR

Read More
24 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For December 13, 2022

By Benzinga Insights
Today, 7:30 AM
Upgrades For Equinix Inc (NASDAQ:EQIX), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In…

AFRM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Raymond James Maintains Outperform on Phreesia, Raises Price Target to $40

By Benzinga Newsdesk
Today, 7:30 AM
Raymond James analyst John Ransom maintains Phreesia (NYSE:PHR) with a Outperform and raises the price target from $35 to $40.

PHR

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin
Today, 7:30 AM
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.

ACER

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

RBC Capital Maintains Sector Perform on Phreesia, Raises Price Target to $26

By Benzinga Newsdesk
Today, 7:30 AM
RBC Capital analyst Sean Dodge maintains Phreesia (NYSE:PHR) with a Sector Perform and raises the price target from $22 to $26.

PHR

Read More
1 minute read
  • Analyst Ratings

Where Phreesia Stands With Analysts

By Benzinga Insights
Today, 7:30 AM
Within the last quarter, Phreesia (NYSE:PHR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PHR

Read More
1 minute read
  • Earnings
  • News

Phreesia Q3 EPS $(0.76) Misses $(0.61) Estimate, Sales $73.10M Beat $70.89M Estimate

By Bill Haddad
Today, 7:30 AM
Phreesia (NYSE:PHR) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.61) by 24.59 percent. This is a 65.22 percent decrease over losses of $(0.46) per share from the same

PHR

Read More
2 minute read
  • Earnings

Earnings Scheduled For December 8, 2022

By Benzinga Insights
Today, 7:30 AM
Companies Reporting Before The Bell • Ciena (NYSE:CIEN) is likely to report quarterly earnings at $0.08 per share on revenue of $849.88 million.

AVGO

Posts navigation

1 2 … 8 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service